A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)

M. Hidalgo, R. Epelbaum, B. M. Wolpin, S. M. Stemmer, R. Geva, T. Golan, E. Borazanci, M. Borad, K. S. Pedersen, J. O. Park, R. Ramirez, A. Peled, T. M. Lustig, O. Bohana Kashtan, O. Rosenfeld, E. Sorani, K. Schlienger, A. Vainstein Haras, D. D. Von Hoff

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii402
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this